Polycystic ovary syndrome affects an estimated 1 in 8 women of reproductive age — making it the most common endocrine disorder in this population worldwide. PCOS is associated with irregular menstrual cycles, androgen excess, metabolic dysfunction, infertility, elevated cardiovascular risk, and significantly higher rates of anxiety and depression. It is not a reproductive condition. It is a systemic condition that affects nearly every organ system across the lifespan.
Despite this, women with PCOS wait an average of two years and see three or more clinicians before receiving a diagnosis. For many, the wait is much longer.
A Condition Medicine Has Misnamed and Misunderstood
The name itself is part of the problem. Polycystic ovary syndrome implies that the defining feature is cysts on the ovaries. It is not. Many women with PCOS do not have ovarian cysts, and many women with cysts do not have PCOS. The Rotterdam diagnostic criteria — the current standard — requires meeting two of three criteria: irregular ovulation, androgen excess, and polycystic ovarian morphology on ultrasound. But clinician unfamiliarity with the criteria, combined with presentations that do not match the stereotypical thin-young-woman-with-irregular-periods image, leads to systematic misdiagnosis.
Women with PCOS who present without the expected phenotype — women of higher weight, women with regular cycles who nonetheless have androgen excess, women whose symptoms are dominated by metabolic rather than reproductive features — are regularly missed.
The Metabolic Stakes
PCOS dramatically elevates the lifetime risk of type 2 diabetes, cardiovascular disease, and endometrial cancer. These risks are modifiable — with appropriate intervention, monitoring, and support — but only if the diagnosis is made. Every year of diagnostic delay is a year in which metabolic risk accumulates unchecked.
The connection between PCOS and mental health is also underappreciated. Women with PCOS have significantly elevated rates of depression and anxiety, linked both to hormonal dysregulation and to the chronic experience of having unexplained symptoms dismissed.
What Improved Care Requires
Diagnostic criteria reform — including renaming the condition to better reflect its systemic nature — has been discussed in the research community for years without resolution. What is not disputed is that clinician education must improve, that symptom patterns currently attributed to lifestyle must be evaluated for underlying PCOS, and that guidelines for PCOS management across the lifespan — including in menopause, where the condition’s metabolic implications continue — need to be developed and implemented.
PCOS is not a niche condition. It is a major public health issue that receives neither the research investment nor the clinical attention its prevalence demands.
